Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
A landmark lawsuit is challenging the patents Myriad Genetics holds on the so-called breast cancer genes — patents that make Myriad the sole provider of a crucial genetic test. Do patents on genes spur research and innovation, or harm patients? Full Article at NPR
DALLAS, Nov. 30, 2009 (GLOBE NEWSWIRE/CRWENewswire) -- BeaconEquity.com announces an investment report featuring Power3 Medical Products Inc. (OTCBB:PWRM - News). Full Article at TransWorldNews
David Gardner's top pick took an epic run of 1,334%! See what he’s recommending that you buy NEXT. Motley Fool CAPS offers a variety of resources to aid Fools in finding tomorrow's leaders. Full Article at Motley Fool
This column is designed to introduce you to some of the valuable trading tools available on the SchaeffersResearch.com Web site. Full Article at SchaeffersResearch.com
SALT LAKE CITY - Myriad Pharmaceuticals Inc. on Friday reported a smaller fiscal first-quarter loss on lower research costs after the company was spun off from Myriad Genetics Inc. Full Article at Minneapolis Star Tribune
SALT LAKE CITY — Myriad Pharmaceuticals Inc. on Friday reported a smaller fiscal first-quarter loss on lower research costs after the company was spun off from Myriad Genetics Inc. Full Article at Newsvine
MYGN) from Sell to Hold. Morgan analyst says, "Following the past two disappointing quarterly reports, we believe growth expectations for Myriad Genetics have come down. Full Article at Street Insider
There are no results for this module. Edit this module to change the search term used to query Wikipedia
There are no results for this module. Edit the module to change the search term used to query related quotes.
There are no results for this module. Edit the module to change the search term used to query Twitter.
